Google DeepMind launched AlphaGenome, an AI tool that identifies genetic mutations driving disease.
AlphaGenome analyses up to one million DNA letters at once.
The system predicts how mutations disrupt gene regulation across different cells and tissues.
Researchers trained the model on public human and mouse genetics databases.
Scientists say it could speed discovery of disease mechanisms and new treatments.
Experts believe AlphaGenome may guide future gene and cancer therapies.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in Beijing, China, with over 15 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Communication and Journalism from the University of Florida. Over the course of his career, he has contributed to major outlets such as The Miami Herald, CNN, and USA Today. Known for his clear and engaging reporting, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
